Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calfactant Therapy for Direct Acute Respiratory Distress Syndrome & Direct Acute Lung Injury in Adults and Children

NCT00682500 is registered in ClinicalTrials.gov with Pneuma Pharmaceuticals Incorporated as lead sponsor.

NCT NCT00682500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00682500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calfactant Therapy for Direct Acute Respiratory Distress Syndrome & Direct Acute Lung Injury in Adults and Children
Lead sponsor
Pneuma Pharmaceuticals Incorporated
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2008
Completion date
February 28, 2011
Enrollment
332 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome, adult